Somatic mutations in the RET proto-oncogene in sporadic medullary thyroid carcinomas

被引：80

作者：

Dvorakova, S. ^{[1
]}

Vaclavikova, E. ^{[1
]}

Sykorova, V. ^{[1
]}

Vcelak, J. ^{[1
]}

Novak, Z. ^{[2
]}

Duskova, J. ^{[3
]}

Ryska, A. ^{[4
,5
]}

Laco, J. ^{[4
,5
]}

Cap, J. ^{[5
,6
]}

Kodetova, D. ^{[7
]}

Kodet, R. ^{[7
]}

Krskova, L. ^{[7
]}

Vlcek, P. ^{[8
]}

Astl, J. ^{[9
]}

Vesely, D. ^{[9
]}

Bendlova, B. ^{[1
]}

机构：

[1] Res Inst Endocrinol, Dept Mol Endocrinol, CR-11694 Prague 1, Czech Republic

[2] Res Inst Endocrinol, Dept Clin Epidemiol, CR-11694 Prague, Czech Republic

[3] Charles Univ Prague, Inst Pathol, Fac Med 1, Prague, Czech Republic

[4] Charles Univ Prague, Dept Pathol, Fac Med, Hradec Kralove, Czech Republic

[5] Univ Hosp, Hradec Kralove, Czech Republic

[6] Charles Univ Prague, Dept Internal Med 2, Fac Med, Hradec Kralove, Czech Republic

[7] Charles Univ Prague, Inst Pathol & Mol Med, Fac Med 2, Prague, Czech Republic

[8] Charles Univ Prague, Dept Nucl Med & Endocrinol, Fac Med 2, Prague, Czech Republic

[9] Charles Univ Prague, Dept ENT & Head & Neck Surg, Fac Med 1, Prague, Czech Republic

来源：

MOLECULAR AND CELLULAR ENDOCRINOLOGY | 2008年 / 284卷 / 1-2期

关键词：

RET proto-oncogene; medullary thyroid carcinoma; somatic mutation; genetics; prognosis;

D O I：

10.1016/j.mce.2007.12.016

中图分类号：

Q2 [细胞生物学];

学科分类号：

071009 ; 090102 ;

摘要：

The frequency and prognostic relevance of RET proto-oncogene somatic mutations in sporadic medullary thyroid carcinoma (MTC) remain controversial. In order to study somatic mutations in the RET proto-oncogene in sporadic MTCs found in the Czech population and to correlate these mutations with clinical and pathological characteristics, we investigated 48 truly sporadic MTCs by sequencing classical risk exons 10, It, 13, 14, 15 and 16. From the 48 tumors studied, 23 (48%) had somatic mutation in the RET proto-oncogene in exons 10, 11, 15 or 16. The classical somatic mutation Met918Thr in exon 16 was only found in 13 tumors (27%). In five cases, multiple somatic mutations and deletions were detected. A statistically significant correlation between the presence of somatic mutation with more advanced pathological TNM stages was observed. Other clinical and pathological characteristics did not show any statistical significant association with the presence or absence of somatic mutation. (C) 2008 Elsevier Ireland Ltd. All rights reserved.

引用

页码：21 / 27

页数：7

共 47 条

[1] A complex nine base pair deletion in RET exon 11 common in sporadic medullary thyroid carcinoma [J].

Alemi, M ;

Lucas, SD ;

Sallstrom, JF ;

Bergholm, U ;

Akerstrom, G ;

Wilander, E .

ONCOGENE, 1997, 14 (17) :2041-2045

[2]

[Anonymous], 2002, AJCC CANC STAGING HD

[3] No correlation between RET immunostaining and the codon 918 mutation in sporadic medullary thyroid carcinoma [J].

Bockhorn, M ;

Frilling, A ;

Kalinin, V ;

Schröder, S ;

Broelsch, CE .

LANGENBECKS ARCHIVES OF SURGERY, 1999, 384 (01) :60-64

[4] The Glu632-Leu633 deletion in cysteine rich domain of Bet induces constitutive dimerization and alters the processing of the receptor protein [J].

Bongarzone, I ;

Vigano, E ;

Alberti, L ;

Mondellini, P ;

Uggeri, M ;

Pasini, B ;

Borrello, MG ;

Pierotti, MA .

ONCOGENE, 1999, 18 (34) :4833-4838

[5] Molecular analysis of the RET proto-oncogene in patients with sporadic medullary thyroid carcinoma: A novel point mutation in the extracellular cysteine-rich domain [J].

Bugalho, MJ ;

Frade, JP ;

Santos, JR ;

Limbert, E ;

Sobrinho, L .

EUROPEAN JOURNAL OF ENDOCRINOLOGY, 1997, 136 (04) :423-426

[6] Identification of RET kinase inhibitors as potential new treatment for sporadic and inherited thyroid cancer [J].

Carlomagno, F ;

Santoro, M .

JOURNAL OF CHEMOTHERAPY, 2004, 16 :49-51

[7]

Carlomagno F, 2002, CANCER RES, V62, P1077

[8] Somatic in frame deletions not involving juxtamembranous cysteine residues strongly activate the RET proto-oncogene [J].

Ceccherini, I ;

Pasini, B ;

Pacini, F ;

Gullo, M ;

Bongarzone, I ;

Romei, C ;

Santamasia, G ;

Matera, I ;

Mondellini, P ;

Scopsi, L ;

Pinchera, A ;

Pierotti, MA ;

Romeo, G .

ONCOGENE, 1997, 14 (21) :2609-2612

[9] Inhibition. of medullary thyroid carcinoma cell proliferation and RET phosphorylation by tyrosine kinase inhibitors [J].

Cohen, MS ;

Hussain, HB ;

Moley, JF .

SURGERY, 2002, 132 (06) :960-966

[10] RET polymorphisms and sporadic medullary thyroid carcinoma in a Portuguese population [J].

Costa, P ;

Domingues, R ;

Sobrinho, LG ;

Bugalho, MJ .

ENDOCRINE, 2005, 27 (03) :239-243

← 1 2 3 4 5 →